RMD · ASX

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX:RMD)

AU$37.83

 0.92 (2.488%)
ASX:Live
06/11/2024 04:10:01 PM
Short Term Trend - Long Recent Price upgrade HALO Price Momentum HALO Ords HALO MQV +9
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

RMD Overview

RMD Health Scores

Short Term

Mean Reversion

Very Strong

Trend

Neutral

Event

Very Weak

Halo Model

MQV

Very Weak

GARP

Weak

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Weak

About RMD

Telephone

Address

Description

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

RMD Price Chart

Key Stats

Market Cap

AU$54.33B

PE

27.40

EV/EBITDA

20.1

Dividends Overview

DIV Yield

.9%

Franking

N/A

Ex Dividend Date (est.)

06-Nov-24

Market Data

52 weeks range

Low 22.19 - 39.13

Trade Value (12mth)

US$10,018,174.00

1 week

0.19%

1 month

6.72%

YTD

45.69%

1 year

54.96%

All time high

40.79

Key Fundamentals

EPS 3 yr Growth

112.60%

EBITDA Margin

34.20%

Operating Cashflow

$1,401m

Free Cash Flow Return

25.10%

ROIC

18.30%

Interest Coverage

26.60

Quick Ratio

1.70

Other Data

Shares on Issue (Fully Dilluted)

1476m

HALO Sector

Next Company Report Date

31-Jul-25

Ex Dividend Date (est.)

06-Nov-24

Next Dividend Pay Date (est.)

12-Dec-24

Reporting Currency

USD

Short Sell (% of issue)

0.19

RMD Announcements

Latest Announcements

Date Announcements

04 November 24

Form 4 - Change of Beneficial Ownership

×

Form 4 - Change of Beneficial Ownership

04 November 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

28 October 24

Form 10-Q for the Quarter Ended September 30, 2024

×

Form 10-Q for the Quarter Ended September 30, 2024

28 October 24

Amendment to Notice of Annual Meeting/Proxy Form

×

Amendment to Notice of Annual Meeting/Proxy Form

25 October 24

ResMed Announces Results for the First Quarter of FY2025

×

ResMed Announces Results for the First Quarter of FY2025

25 October 24

Dividend/Distribution - RMD

×

Dividend/Distribution - RMD

17 October 24

Form 4 - Statement of Changes in Beneficial Ownership

×

Form 4 - Statement of Changes in Beneficial Ownership

14 October 24

Form 144 - Notice of Proposed Sale of Securities

×

Form 144 - Notice of Proposed Sale of Securities

10 October 24

Form 4 - Statement of Changes in Beneficial Ownership

×

Form 4 - Statement of Changes in Beneficial Ownership

10 October 24

Form 4 - Statement of Changes in Beneficial Ownership

×

Form 4 - Statement of Changes in Beneficial Ownership

09 October 24

Form 144 - Notice of Proposed Sale of Securities

×

Form 144 - Notice of Proposed Sale of Securities

09 October 24

Form 144 - Notice of Proposed Sale of Securities

×

Form 144 - Notice of Proposed Sale of Securities

04 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

04 October 24

Notice of Annual General Meeting Additional Materials

×

Notice of Annual General Meeting Additional Materials

04 October 24

ResMed to Report First Quarter Fiscal 2025 Results

×

ResMed to Report First Quarter Fiscal 2025 Results

03 October 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

04 September 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

19 August 24

Director Appointment/Resignation

×

Director Appointment/Resignation

19 August 24

Update - Dividend/Distribution - RMD

×

Update - Dividend/Distribution - RMD

12 August 24

ResMed Form 10-k Annual Report

×

ResMed Form 10-k Annual Report

05 August 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

02 August 24

ResMed Announces Results for the Fourth Quarter of FY2024

×

ResMed Announces Results for the Fourth Quarter of FY2024

02 August 24

Dividend/Distribution - RMD

×

Dividend/Distribution - RMD

04 July 24

ResMed to Report Fourth Quarter Fiscal 2024 Results

×

ResMed to Report Fourth Quarter Fiscal 2024 Results

02 July 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

RMD Fundamentals

Per Share Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.53 0.61 0.69 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.53 0.61 0.69 Lock Lock Lock
     Growth % Lock Lock Lock Lock 63.4 14.6 13.5 Lock Lock Lock
     PE X Lock Lock Lock Lock 43.1 34.1 27.4 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 30.4 24.9 20.1 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.72 0.79 0.92 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.02 0.21 0.69 Lock Lock Lock
     Growth % Lock Lock Lock Lock 43.3 8.6 17.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.1 1.0 3.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.12 0.15 0.19 Lock Lock Lock
     Growth % Lock Lock Lock Lock 9.9 22.6 31.8 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.7 0.8 0.9 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 23 24 28 Lock Lock Lock
BPS $ Lock Lock Lock Lock 2.30 2.81 3.31 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.74 0.55 1.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock 89.8 -25.5 90.5 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,470 1,475 1,476 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,461 1,468 1,470 Lock Lock Lock

Financial Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 3,578 4,223 4,685 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.9 18.0 10.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 993 1,162 1,225 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 1,993 2,314 2,609 Lock Lock Lock
     Growth % Lock Lock Lock Lock 10.2 16.1 12.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 55.7 54.8 55.7 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 44 45 44 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 1,194 1,349 1,600 Lock Lock Lock
     Growth % Lock Lock Lock Lock 8.2 12.9 18.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 33.4 31.9 34.2 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 194 197 216 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 1,000 1,152 1,384 Lock Lock Lock
     Growth % Lock Lock Lock Lock 9.6 15.2 20.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 28.0 27.3 29.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 960 1,102 1,265 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 181 204 244 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 779 898 1,021 Lock Lock Lock
     Growth % Lock Lock Lock Lock 64.3 15.2 13.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 21.8 21.3 21.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 351 693 1,401 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 156 134 115 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -230 -1,160 -270 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -128 423 -1,119 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 216 574 1,302 Lock Lock Lock
     Growth % Lock Lock Lock Lock -65.9 165.2 126.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.1 0.1 0.3 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 274 228 238 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 5,096 6,752 6,872 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 886 1,548 839 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 644 1,352 636 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1,735 2,622 2,008 Lock Lock Lock
Equity $m Lock Lock Lock Lock 3,544 4,173 4,773 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 4,247 5,678 5,703 Lock Lock Lock
     Growth % Lock Lock Lock Lock 16.5 33.7 0.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 15.3 13.3 14.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 22.0 21.5 21.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 24.8 23.1 24.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 19.5 18.1 18.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 8.8 14.0 25.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 53.5 22.2 26.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.5 1.0 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 18.2 32.4 13.3 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.8 3.1 2.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.7 1.8 1.7 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 14.2 9.6 10.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 50.9 91.4 153.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 5.8 6.3 5.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 2.6 2.2 2.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.7 2.6 3.3 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 4.7 3.6 5.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.7 0.6 0.7 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.7 0.6 0.7 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 26.8 26.1 27.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 18.8 16.3 18.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 18.8 18.5 19.3 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 15.3 13.3 14.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.6 1.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 22.0 21.5 21.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 77.4 75.8 72.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 17.0 16.3 15.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 141.2 165.9 157.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 63.2 57.6 61.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 204.3 223.5 219.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 28.5 25.7 36.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 175.8 197.9 182.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

06-Nov-24

DIV Yield

.9%

Franking Level

N/A

DPSg

31.80%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.19%

Value ($M)

44

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

RMD Shortsell

Frequently Asked Questions

The current share price of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is AU$37.83.
The 52-week high share price for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is AU$39.13.
The 52-week low share price for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX)? is AU$22.19.
The current TTM dividend payout for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is 0.90.
The last dividend payment of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is AU$0.08.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) has a franking level of 0.0%.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is classified in the Healthcare.
The current P/E ratio for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is 27.40.